|
|
| MRD / Regn No. |
: 2738 |
Date |
: 13/06/2026 |
| Patient Name |
: Deepasree Chatterjee |
Age & Gender |
: 55 Yrs. / Female |
| Contact No. |
: 9831139019 |
UHID |
: |
| Ht / Wt / BMI |
: 153 / 52 / 22.21 |
BP S / BP D |
: 101 / 58 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (24/Mar/2015) | HYPOTHYRODISM (24/Mar/2023) | |
| Salient Investigations |
: |
TGL TRIGLYCERIDE: 261 mg/dL | CREATININE: 0.58 | FASTING PLASMA GLUCOSE (FPG): 107 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 8.6 % | LDL LOW DENSITY LIPOPROTEIN: 62 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 120 mg/dL | TSH THYROID STIMULATING HORMONE: 4.9 mIU/L | TGL TRIGLYCERIDE: 261 mg/dL | CREATININE: 0.58 | EGFR EGLOMERULAR FILTRATION RATE: 115.44 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 107 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 8.6 % | LDL LOW DENSITY LIPOPROTEIN: 62 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 120 mg/dL | TSH THYROID STIMULATING HORMONE: 4.9 mIU/L | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION GLARGINE (INJ U100)
BASALOG
Medicine For GLUCOSE CONTROL |
SQ |
0-0-20 |
BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE LOW BLOOD SUGAR | |
|
2 |
ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG
ZEXRIDA 10 |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
3 |
REPAGLINIDE 2 MG + METFORMIN 500 MG
EUREPA MF |
PO |
1-1-0 |
BEFORE BREAKFAST AND LUNCH
|
TILL NEXT VISIT |
|
|
4 |
ATORVASTATIN 20 MG
TONACT 20 MG |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
5 |
ANTIHYPERGLYCEMIC SEMAGLUTIDE 0.25 MG
USEMA 0.25 |
SC |
ONCE A WEEK |
AFTER BREAKFAST
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 13/Dec/2026 |
| Tests Suggested For Next Visit |
: HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE,CREATININE |
| |
|
| |
|
